GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Animal Imaging

$308,777
Hongbiao Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2022 · CA

Animal Imaging

$308,777
Hongbiao Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2021 · CA

Project 2 - Membrane trafficking in EBV malignancies: Implication of deubiquitinase UCH-L1

$308,775
Joseph S Pagano · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA

Impact of IKKB and AurK Inhibitors on Host Immunity and Melanoma

$308,657
Ann Richmond · Vanderbilt University · R01 · FY2013 · CA

Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer

$308,516
Gustavo Ayala · University Of Texas Hlth Sci Ctr Houston · R01 · FY2015 · CA

The Role of Follicular CD8+ T Cells in Pathogenesis of AIDS-NHL.

$308,506
Marta Epeldegui · University Of California Los Angeles · R01 · FY2020 · CA

IL12 Gene Therapy For Enhancing Therapeutic Efficacy of Bleomycin Against Oral Tu

$308,475
Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA

Enzyme-instructed self-assembly for anticancer nanomedicine

$308,474
Bing Xu · Brandeis University · R01 · FY2014 · CA

Cleared Tissue Large FOV Microscope Request

$308,440
Adam I Marcus · Emory University · S10 · FY2022 · OD

Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow

$308,431
Theresa M Busch · University Of Pennsylvania · R01 · FY2011 · CA

Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow

$308,431
Theresa M Busch · University Of Pennsylvania · R01 · FY2010 · CA

Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow

$308,431
Theresa M Busch · University Of Pennsylvania · R01 · FY2008 · CA

Effects of Photodynamic Therapy on Tumor Oxygenation and Blood Flow

$308,431
Theresa M Busch · University Of Pennsylvania · R01 · FY2009 · CA

Project 3 Gene Mediated Cytotoxic Immmunotherapy for GBM

$308,393
E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2017 · CA

Potential of a dominant-negative FGF mutant as a therapeutic in cancer

$308,370
Yoshikazu Takada · University Of California At Davis · R01 · FY2011 · CA

A Phase I safety & immunogenicity study of an HPV16-specific therapeutic protein, TA-CIN, administered intratumorally with chemoradiation in patients with cervical cancer stratified by HPV16 infection

$308,365
T.-C. Wu · Johns Hopkins University · P50 · FY2020 · CA

Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism

$308,362
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2019 · CA

Prx1 in malignant progression of prostate cancer

$308,289
Young-Mee Park · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA

Targeting oncogenic epigenetic mechanisms in IDHmut/ATRXloss Astrocytoma

$308,237
Yunqing Li · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2025 · NS

EGR2 in T cell tolerance

$308,179
Thomas F Gajewski · University Of Chicago · R01 · FY2013 · CA

Engineering Polymers for Gene Therapy of Head Cancer

$308,161
Hamid Ghandehari · University Of Utah · R01 · FY2014 · CA

Integrins in Cancer Invasion

$308,090
Vito Quaranta · Vanderbilt University · R01 · FY2007 · CA

Animal Imaging

$308,071
Hongbiao Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2019 · CA

Computational pathology software for integrative cancer research with three-dimensional digital slides

$308,056
Jun Kong · Georgia State University · U01 · FY2021 · CA

Role of PI3Kinase in Tumor Progression and Metastasis

$308,036
Judith A. Varner · University Of California, San Diego · R01 · FY2018 · CA